WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

Nike, Inc. (NKE) Stock Analysis

OW

NKE Equity Research — OVERWEIGHT — June 2026

← MCDSBUX →

Rating date

Jun 25, 2026

46 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

6p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · NKE

Here is the analysis.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • NKE is in a sustained, confirmed downtrend across all timeframes. Price is below the 50-day SMA, below the 200-day SMA, and the gap between the two is widening.
  • Momentum is bearish and accelerating lower. RSI at 36 (trending down) and MACD at -0.53 (freshly negative and declining) both point to continued downside pressure.
  • The stock is testing the lower Bollinger Band (~$41.14) but has not yet broken below it decisively. A break below could trigger a further leg down, while a bounce off the band would be the first sign of stabilization.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

NKE Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

32 min read

WebserviceX · Agentic Research Desk

NKE Equity Research Note

Published Jun 25, 2026 · Desk view OVERWEIGHT · Generated 2026-06-26T08:18:39Z · Maintained by Walter Vijayakumar · Methodology · Track record

NKE Stock Rating Summary

NKE bias

OVERWEIGHT

Horizon

Long-term

NKE key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

NKE catalyst watch

NKE is in a sustained, confirmed downtrend across all timeframes. Price is below the 50-day SMA, below the 200-day SMA, and the gap between the two is widening.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 6p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:22.171730+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

-7.45%

Vol (20D ann.)

+37.81%

vs SPY: -6.80%

Close 40.9 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · NKE

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace ec360ac9…

No QC issues recorded.